Mounjaro clicks per pen: what the count tells you about cost

The myth: more clicks means more medicine, so lower doses cost less per pen

This is a question our prescribers hear most weeks, and the confusion is understandable. Because Mounjaro pens are titrated upward through six strengths (starting at 2.5mg and rising through 5, 7.5, 10, 12.5, and 15mg) people assume that a lower-dose pen must contain less product and therefore cost less. In practice, the KwikPen format works differently. Each pen, regardless of strength, is designed to deliver exactly four weekly doses. The click mechanism controls the volume and concentration per dose, not the total number of injections you get. You always get four weeks from one pen. What changes across the titration schedule is the dose of tirzepatide in each of those four clicks, not the number of clicks itself.

This matters for cost because private providers typically price per pen, meaning a single pen equals one month's supply at whatever strength you're on. The price per pen is what moves as you move up the schedule, not the quantity of pens you need. If you see a headline price and want to understand it properly, the first question to ask is which strength it refers to, and what it actually includes.

For a fuller breakdown of how pen prices vary by dose in the UK private market, the Mounjaro pen prices page covers the landscape in detail.

What UK private pricing actually includes, and what it often doesn't

The private market for Mounjaro in the UK is genuinely varied, and headline figures don't always tell the whole story. Some services charge separately for consultations; others fold in the prescription fee but add a delivery charge; a few offer ongoing clinical review as part of the price while others treat each contact as an add-on. That's before you factor in what happens if you need aftercare support between doses, or if a dose review is clinically indicated.

Following Eli Lilly's list price revision in September 2025 (the highest-dose pen's list price rose from around £122 to around £330 per four-week pen) typical private market prices sit broadly between £149 and £375 per month by dose and provider, as widely reported. Those are real costs, and no serious service hides them. But a lower headline figure that excludes a consultation fee, a delivery charge, or any aftercare access can close the gap quickly. The cost of a Mounjaro pen page works through what drives those differences.

It's also worth noting that whether you're on 5mg or 15mg, Mounjaro remains a prescription medicine throughout, meaning legitimate access always requires a clinical review before each supply, regardless of how the price is presented. The Mounjaro 5mg pen price page looks specifically at starter-dose pricing if that's your starting point.

Where nume sits in this, and why we're not competing on price

One transparent price. That's the short version. At nume, the consultation, the prescription, the medicine, the delivery and 7-day aftercare are included. No separate booking fee. No add-on delivery charge. No subscription that renews automatically. We're not the cheapest option on the market, that's a deliberate choice, not an oversight. Cheapest isn't a race we entered, because the economics of being cheapest tend to come at the cost of something clinical: the depth of the review, the speed of prescriber access, the quality of aftercare when something comes up.

Every order is personally reviewed by a GPhC-registered Independent Prescriber before dispatch, a real clinician reads your answers, not software processing a form. Order before 12pm Monday to Friday and, once clinically approved, treatment is dispatched the same day and delivered free the next working day by DPD. Current treatment pricing is on the treatment page. If you want to check whether the market is moving, the is Mounjaro getting cheaper page covers recent pricing trends honestly.

You can verify our GPhC pharmacy registration at any point, premises number 9012878, searchable directly on the GPhC register.

Why 'cheapest per pen' is the wrong question for a prescription medicine

Price is a reasonable thing to consider. It becomes the wrong test when it's the only test. Mounjaro is a Prescription-Only Medicine; the MHRA has documented large-scale seizures of counterfeit tirzepatide pens (including the first illicit UK manufacturing site, raided in Northampton in October 2025) with some fake pens found to contain the wrong active ingredient entirely. Sellers offering these medicines without a clinical assessment, through social media or unverified websites, often compete on price precisely because they're cutting the parts that cost money: the genuine licensed supply chain, the pharmacist's time, the prescriber's accountability.

The right questions are: is this pharmacy on the GPhC register? Is a qualified prescriber reviewing my case before each supply? Is this medicine from the licensed UK supply chain? The cheap Mounjaro pen page addresses this in more depth, including the red flags worth knowing before you buy anywhere. The MHRA Drug Safety Updates page is also worth bookmarking if you're weighing up providers, it covers the counterfeit warnings and safety communications that apply to GLP-1 medicines.

For a broader picture of what treatment involves, the weight-loss treatment overview is a good place to start.